Artelo Biosciences Inc (NAS:ARTL)
$ 1.06 0.01 (0.95%) Market Cap: 3.42 Mil Enterprise Value: -1.36 Mil PE Ratio: 0 PB Ratio: 0.54 GF Score: 32/100

Artelo Biosciences Inc Annual Shareholders Meeting Transcript

Jun 30, 2023 / 03:00PM GMT
Release Date Price: $1.99 (+0.76%)
Operator

Good morning, and welcome to the Artelo Biosciences, Inc 2023 annual meeting of stockholders. I'll now turn the call over to Gregory Gorgas. You may begin.

Gregory Gorgas
Artelo Biosciences, Inc. - President, CEO

Thank you. I want to begin by wishing everyone a good day. My name is Greg Gorgas, and I'm the President and Chief Executive Officer of Artelo Biosciences, Incorporated. It's a pleasure to welcome you to the 2023 annual meeting of stockholders of Artelo. We will begin today with the formal business of the meeting and will follow with a question and answer session.

Before proceeding further, I'd like to introduce the company's directors who are present virtually at this meeting. We have Connie Matsui for Chair; Steven Kelly, Director; Gregory Reyes MD, PhD, Director in attendance.

Finally, I'd like to introduce Leah Gonzales from our auditors at Malone Bailey LLP, who is present during this meeting; and Mahnaz Dodge, our legal counsel from Wilson Sonsini Goodrich & Rosati. We have ask Mahnaz Dodge to act as Secretary of the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot